Is Ferric Carboxymaltose a Safer Option Compared to Iron Sucrose?
dc.authorid | SARICI, Ahmet/0000-0002-5916-0119 | |
dc.authorid | Tanriverdi, Lokman Hekim/0000-0003-4263-5234 | |
dc.authorwosid | SARICI, Ahmet/ABI-7512-2020 | |
dc.authorwosid | Tanriverdi, Lokman Hekim/M-5701-2015 | |
dc.contributor.author | Sarici, Ahmet | |
dc.contributor.author | Tanriverdi, Lokman Hekim | |
dc.date.accessioned | 2024-08-04T20:59:47Z | |
dc.date.available | 2024-08-04T20:59:47Z | |
dc.date.issued | 2023 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.identifier.endpage | S384 | en_US |
dc.identifier.issn | 2152-2650 | |
dc.identifier.issn | 2152-2669 | |
dc.identifier.startpage | S384 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/103513 | |
dc.identifier.volume | 23 | en_US |
dc.identifier.wos | WOS:001062479600355 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Cig Media Group, Lp | en_US |
dc.relation.ispartof | Clinical Lymphoma Myeloma & Leukemia | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | MPN | en_US |
dc.subject | ferric carboxymaltose | en_US |
dc.subject | FCM | en_US |
dc.subject | iron deficiency anemia | en_US |
dc.subject | IDA | en_US |
dc.title | Is Ferric Carboxymaltose a Safer Option Compared to Iron Sucrose? | en_US |
dc.type | Conference Object | en_US |